Ranking tables
Healthcare: Pharmaceutical/Medical Products Regulatory | USA
District of Columbia
Band 3
Goodwin
Morgan, Lewis & Bockius LLP- Hyman Phelps & McNamara
Band 4
Senior Statespeople
- Jonathan S Kahan Hogan Lovells US LLP
Peter O Safir Covington & Burling LLP- Jeffrey N GibbsHyman Phelps & McNamara
Band 1
Band 2
Cathy Burgess Alston & Bird LLP
Denise Esposito Covington & Burling LLP
Elizabeth Richards Latham & Watkins LLP
Gregory Levine Ropes & Gray LLP
Kathleen M Sanzo Morgan, Lewis & Bockius LLP
Nathan Brown Akin- Philip Katz Hogan Lovells US LLP
Raymond A Bonner Sidley Austin LLP
Rebecca K. Wood Sidley Austin LLP
William B Schultz Zuckerman Spaeder LLP
William McConagha Latham & Watkins LLP- Scott M. LassmanLassman Law + Policy
Band 3
Brian Waldman ArentFox Schiff LLP- David Horowitz Hogan Lovells US LLP
J Benneville Haas Latham & Watkins LLP
John D. Shakow King & Spalding LLP
Julie Tibbets Goodwin
Kevin Madagan McGuireWoods LLP
Krista Hessler Carver Covington & Burling LLP
Mark S Brown King & Spalding LLP- Meredith Manning Hogan Lovells US LLP
- Michael Heyl Hogan Lovells US LLP
Nikki Reeves King & Spalding LLP
Paul D. Rubin Debevoise & Plimpton LLP
Seth H Lundy King & Spalding LLP- Kurt KarstHyman Phelps & McNamara
Band 4
Deeona Gaskin Sidley Austin LLP
Howard Sklamberg Arnold & Porter
James R Johnson Sidley Austin LLP- John J Smith Hogan Lovells US LLP
Lee H Rosebush BakerHostetler LLP
Mahnu Davar Arnold & Porter
Michael M. Gaba Polsinelli PC
Pamela Forrest Covington & Burling LLP
Paul Radensky McDermott Will & Emery LLP
Peggy Dotzel Zuckerman Spaeder LLP
Peter Lindsay Paul Hastings LLP- Sonia Nath Cooley LLP
- Edward John AlleraBuchanan Ingersoll & Rooney PC
- Josephine TorrenteHyman Phelps & McNamara
Band 5
Up and Coming
Associates to watch
Band 1
1 Covington & Burling LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 1 |Covington & Burling LLP is a powerhouse in the pharmaceutical and medical device industry with extensive experience advising on product development, manufacturing and pharmacovigilance. Retained by clients for its proficiency dealing with regulatory bodies, including the FDA and Consumer Product Safety Commission.
1 Hogan Lovells US LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 1 |Hogan Lovells is a distinguished team with deep expertise across the scope of the healthcare and life sciences industries. The firm handles complex issues including the regulation of new medical devices, biotechnology products and healthcare litigation, government price reporting, privacy and reimbursement issues and digital health. The team's expertise also extends to advising on transactions such as clinical integrations, M&A and contracting.
1 Sidley Austin LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 1 |Sidley Austin is a multitalented team that attracts an impressive breadth of work in the sector, representing both healthcare providers and manufacturers in relation to complex clinical matters, including research trial compliance. It advises on an array of regulatory issues including pricing, reimbursement and coverage. The firm is frequently retained on high-stakes government investigations, with experience across criminal and civil matters.
Band 2
2 Arnold & PorterHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 2 |Impressive team with wide-ranging expertise in healthcare, pharmaceutical and medical device matters, including innovative technology and compliance issues. Integrated life sciences practice offers strong IT services to clients, alongside FDA and healthcare regulatory compliance counseling. Notable litigation capabilities include both civil and criminal defense work. Offers strength acting for organizational as well as individual clients in the healthcare space.
2 King & Spalding LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 2 |King & Spalding has strong regulatory and litigation capabilities, frequently advising on high-value Medicare reimbursement appeals for hospitals. The firm also acts on M&A and joint ventures involving providers, as well as health IT concerns. The team is also noted for its experience in the pharmaceutical and biotech space, advising on areas such as clinical trials, marketing and disputes and offering skill in handling drug-pricing issues for pharmaceutical manufacturers.
2 Latham & Watkins LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 2 |Latham & Watkins' team advises a wide range of healthcare entities, including hospitals, laboratories and distributors, on complex investigations and transactions. Its interdisciplinary approach offers clients varied expertise in areas such as qui tam litigation and capital markets investment. The firm also acts on administrative challenges and FDA regulatory issues. The teams clients additionally include companies in the pharmaceutical, medical device manufacturing and biotech industries.
2 Ropes & Gray LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 2 |Robust practice sought after for a range of matters spanning healthcare, medical device and pharmaceutical issues. Offers substantial experience in regulatory issues including compliance and investigations work, coupled with pharmaceutical expertise encompassing advertising and patent advice. Also noted for arguing cases in trial and appellate courts.
Band 3
3 GoodwinHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 3 |Counsels a broad range of clients including pharmaceuticals and medical device manufacturers on complex FDA regulatory issues. Noted for its significant expertise in compliance related to new drug and device development and its strong cross-border capabilities. Also acts on transactions such as the sale of drug rights.3 Morgan, Lewis & Bockius LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 3 |Demonstrates extensive capabilities in health law compliance matters, including investigations and other regulatory challenges. Attracts a broad roster of clients, including healthcare service providers, pharmaceutical and biotech companies. Frequently acts on civil and criminal litigation, as well as representing private equity firms in high-value healthcare acquisitions. Offers notable expertise in advising on complex coverage and reimbursement issues. Also noted for its FDA regulatory capabilities.- Hyman Phelps & McNamaraHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 3
Band 4
4 AkinHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |A strong force in the healthcare market that acts for multiple high-profile clients. Excels across the range of regulatory and litigation work, regularly representing clients in investigations and disputes with government bodies. Expertise includes Medicare reimbursement disputes and False Claims Act claims. Also possesses experience advising healthcare clients on due diligence and other aspects of transactional matters.
4 Alston & Bird LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |Offers a wealth of expertise in FDA enforcement and compliance matters, with broad cross-border capabilities. Noted for advising drug manufacturers on a range of issues including warning letters, HIPAA and fraud and abuse matters. Also counsels on compliance issues in new product developments.
4 ArentFox Schiff LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |Strong team noted for its handling of wide-ranging matters, including regulatory compliance, external investigations and litigation. Particularly adept at fraud and abuse matters, with significant expertise in high-stakes False Claims Act matters. Also offers experience in drug pricing and FDA regulatory issues for pharmaceutical and medical device companies.
4 BakerHostetler LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |Notable experience in high-profile FDA mandates. Regularly advises pharmaceutical clients and providers as well as private equity funds on regulatory issues such as those connected to new drug applications and advertising matters. Expertise in negotiating pharmacy benefit management contracts. Also offers strong skills in a broad range of transactions including sale of assets and joint ventures.
4 McDermott Will & Emery LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |McDermott Will & Emery are a premier group with diverse subject matter expertise, handling complex transactional and regulatory matters for an enviable client list. The firm represents a range of clients, notably healthcare providers and private equity firms, across the full spectrum of healthcare work, including lobbying and policy matters. It regularly advises on civil litigation and high-stakes enforcement proceedings. The team's expertise extends to FDA regulatory compliance.
4 Reed Smith LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |Excellent healthcare team that maintains a strong profile for regulatory work, including reimbursement and transactional due diligence. Regularly advises care providers, investors and new technology manufacturers, among others. Experience includes advising on external investigations conducted by government bodies such as the DOJ. Also counsels pharmaceutical and medical device manufacturers on FDA regulation and fraud and abuse matters.
4 Skadden, Arps, Slate, Meagher & Flom LLP & AffiliatesHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 4 |Well-regarded team offering knowledge across a broad range of industry concerns. Provides high-level advice on regulatory compliance and enforcement proceedings. Noted for strength in both civil and criminal litigation, and also draws on significant transactional capabilities. Acts for a range of life sciences companies alongside providers, fielding increasing strength in FDA regulatory issues. Also noted for its handling of issues arising from the opioid sector.
Band 5
5 Baker McKenzieHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 5 |The Baker McKenzie team offers broad expertise in a range of regulatory issues, including, but not limited to, FDA regulatory compliance and the commercialization of products. The team has significant experience of handling transactions. The lawyers are also called upon to provide counsel on the development of internal compliance protocols. The group routinely advises pharmaceutical and medical device companies.
5 Morrison FoersterHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 5 |Morrison Foerster provides expert advice for a range of organizations in the life science and healthcare space. The team demonstrates its ability to handle a plethora of issues, including complex litigation, high-profile transactions and regulatory compliance. The group is notably adept at advising clients on FDA regulation and compliance.
5 Paul Hastings LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 5 |Paul Hastings' team is held in high regard for its ability to provide counsel to pharmaceutical companies and manufacturers on FDA regulation, inspections and enforcement. Its practitioners have further experience advising clients on M&A deals.
5 Polsinelli PCHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 5 |Polsinelli has a significant healthcare practice. The practitioners are routinely called upon to assist with FDA regulatory issues. The team is noted for their representation of medical device manufacturers in a range of issues. They are adept at handling matters related to HIPAA compliance, data privacy and security, as well as Medicare coverage and payment issues.
5 Zuckerman Spaeder LLPHealthcare: Pharmaceutical/Medical Products Regulatory2024 | Band 5 |Zuckerman Spaeder's group boasts considerable strength in the healthcare space. The team is notably adept at advising clients on regulatory and transactional issues. Its practitioners demonstrate particular prowess in assisting organizations on fraud and abuse matters and government investigations.